Iraq vs Yemen: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Iraq
0.4%
in 2024
Yemen
0.5%
in 2024
Iraq rank
74th
Yemen rank
71st
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Iraq
- Yemen
How they compare
Yemen currently reports 0.5% against 0.4% in Iraq, a difference of 0.1%.
That makes Yemen's figure about 1.2 times Iraq's.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Iraq ahead.
Iraq ranks 74th and Yemen ranks 71st of 246 countries.
Iraq has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Iraq | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.8% | 0.6% | 0.1% | Iraq |
| 2020s | 0.5% | 0.5% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Iraq or Yemen?
- Yemen, at 0.5% against 0.4% in Iraq as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Iraq and Yemen?
- 0.1%, with Yemen ahead.
- How many years of comparable data are there for Iraq and Yemen?
- 10 years are reported by both, from 2015 to 2024.
- How do Iraq and Yemen rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Iraq ranks 74th and Yemen ranks 71st of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.